- Ripple has cemented its place among the world’s most valuable private companies, now valued at over $15 billion.
- XRP is showing resilience, holding steady around the $2.73 support level and setting its sights on breaking through the $3.65 resistance zone.
CB Insights recently published its latest list of unicorn companies, private startups valued at over $1 billion, and the numbers are staggering. There are now 1,276 unicorns worldwide, collectively worth around $4.42 trillion.
Ripple, backed by investors like IDG Capital, Venture51, and Lightspeed Venture Partners, first joined this exclusive list back in December 2019 and has continued to climb ever since.
Today, Ripple Labs ranks 23rd globally with a $15 billion valuation, putting it ahead of well-known names like Klarna and defense startup Anduril. In fact, Ripple is one of 31 U.S. companies among the world’s top 50 most valuable private firms, a testament to how far it has come in blending blockchain innovation with traditional finance.
For perspective, the top five unicorns include SpaceX valued at $350 billion, ByteDance and OpenAI each at $300 billion, Stripe at $70 billion, and SHEIN at $66 billion. Ripple’s ranking firmly establishes it as one of the leading players in global financial technology.
Naturally, this milestone has sparked one big question across the crypto community: Can XRP, Ripple’s native token, follow suit with a breakout of its own? Despite recent market volatility, XRP is showing promising signs.
Analyst Ali Martinez recently noted on X that XRP could find key support around $2.55–$2.40 and face resistance near $3.35–$3.60. A breakout above this zone could open the door for bigger gains, with forecasts projecting double-digit XRP prices by 2030, possibly reaching $10 or even $12.
Currently, the token is trading at $3.00, just 21% below its ATH, $3.84.
The Ripple Effect of Regulation & Partnerships
Ripple’s long-running legal battle with the U.S. Securities and Exchange Commission (SEC), which once cast a shadow over XRP, may finally be nearing its conclusion. The crypto community is watching closely as August 15 approaches, a key date when the SEC is expected to formally drop its appeal, prompting Ripple to do the same.
From there, both sides will file the paperwork to officially close the case, potentially bringing years of uncertainty to an end.
Ripple’s ecosystem is expanding at an impressive pace. Wellgistics Health recently filed its S‑1 registration statement, outlining plans to integrate Ripple’s blockchain technology throughout its operations. With a network that reaches roughly 6,000 pharmacies and 150 drug manufacturers, the company intends to use the XRP Ledger for real-time B2B invoicing.
On top of that, there is growing speculation about an XRP ETF. According to Polymarket data, the odds of approval by year’s end have surged to 86%, with some analysts predicting a green light as early as September.
Major financial players like Franklin Templeton, 21Shares, WisdomTree, ProShares, CoinShares, and Bitwise have already submitted applications.
Ripple’s network continues to expand, too, boasting over 300 banking partnerships since its founding in 2012. On the trading side, Coinbase Derivatives plans to roll out nano XRP and SOL futures on August 18, offering smaller contract sizes and up to 10x leverage, giving U.S. traders more accessible futures options without relying on offshore exchanges.
Earlier this year, Teucrium’s XRP Futures ETF pulled in $5.3 million on day one, a sign of strong demand for XRP-linked financial products and a possible mirror to what we might see after an XRP ETF approval by the SEC.
